Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2011-2020 of 10948

Edit search filters
  1. Rituximab in Progressive IgA Nephropathy

    Rochester, MN

  2. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

    Rochester, MN

  3. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    Rochester, MN

  4. A Study to Evaluate MM-151, Nal-IRI, 5-FU, and Leucovorin for RAS/RAF Wild-Type Metastatic Colorectal Cancer

  5. A Study of a Comprehensive Weight Loss Program for Mayo Clinic Employees, at the Dan Abraham Healthy Living Center

    Rochester, MN

  6. A Study to Test the Use of the E-PAL Mobile Application for Pain Management in Cancer Patients

    Rochester, MN

  7. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

    Rochester, MN

  8. Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

    Rochester, MN

  9. A Study to Assess Transfusion Requirements in Cardiac Surgery

    Rochester, MN

  10. A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

    Rochester, MN

.

Mayo Clinic Footer